2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+))

C88H68F15N37Pt5 — CID 157190481

IUPAC2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+))
SMILESCc1cc(-c2cc(F)ccn2)[n-]n1.Cc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Cc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Cc1cnc(-c2cc(C)n[n-]2)cn1.Cc1cnc(-c2cc(C)n[n-]2)cn1.Cc1n[n-]c(-c2cnccn2)c1C.Cc1n[n-]c(-c2cnccn2)n1.Cc1n[n-]c(-c2cnccn2)n1.Fc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Fc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/2C10H7F3N3.2C9H4F4N3.C9H7FN3.3C9H9N4.2C7H6N5.5Pt/c2*1-6-2-3-14-7(4-6)8-5-9(16-15-8)10(11,12)13;2*10-5-1-2-14-6(3-5)7-4-8(16-15-7)9(11,12)13;1-6-4-9(13-12-6)8-5-7(10)2-3-11-8;2*1-6-3-8(13-12-6)9-5-10-7(2)4-11-9;1-6-7(2)12-13-9(6)8-5-10-3-4-11-8;2*1-5-10-7(12-11-5)6-4-8-2-3-9-6;;;;;/h2*2-5H,1H3;2*1-4H;2-5H,1H3;3*3-5H,1-2H3;2*2-4H,1H3;;;;;/q10*-1;5*+2
InChIKeyAPQFVUUKAJLOQX-UHFFFAOYSA-N
MW2904.13 g/mol
LogP14.65
Rot. Bonds10

About 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+))

2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+)) (PubChem CID 157190481) has the molecular formula C88H68F15N37Pt5 and a molecular weight of 2904.13 g/mol. Its IUPAC name is 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+)).

Molecular Properties

Compound Name2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+))
PubChem CID157190481
Molecular FormulaC88H68F15N37Pt5
Molecular Weight2904.13 g/mol
Exact Mass2902.45
IUPAC Name2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+))
SMILESCc1cc(-c2cc(F)ccn2)[n-]n1.Cc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Cc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Cc1cnc(-c2cc(C)n[n-]2)cn1.Cc1cnc(-c2cc(C)n[n-]2)cn1.Cc1n[n-]c(-c2cnccn2)c1C.Cc1n[n-]c(-c2cnccn2)n1.Cc1n[n-]c(-c2cnccn2)n1.Fc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Fc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/2C10H7F3N3.2C9H4F4N3.C9H7FN3.3C9H9N4.2C7H6N5.5Pt/c2*1-6-2-3-14-7(4-6)8-5-9(16-15-8)10(11,12)13;2*10-5-1-2-14-6(3-5)7-4-8(16-15-7)9(11,12)13;1-6-4-9(13-12-6)8-5-7(10)2-3-11-8;2*1-6-3-8(13-12-6)9-5-10-7(2)4-11-9;1-6-7(2)12-13-9(6)8-5-10-3-4-11-8;2*1-5-10-7(12-11-5)6-4-8-2-3-9-6;;;;;/h2*2-5H,1H3;2*1-4H;2-5H,1H3;3*3-5H,1-2H3;2*2-4H,1H3;;;;;/q10*-1;5*+2
InChIKeyAPQFVUUKAJLOQX-UHFFFAOYSA-N
XLogP14.65
TPSA489.03 Ų
H-Bond Donors
H-Bond Acceptors27
Rotatable Bonds10
Heavy Atoms145
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002904.13
LogP ≤ 514.65
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1027

Analyze 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+))?
The IUPAC name of 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+)) (CID 157190481) is 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+)).
What is the SMILES notation for 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+))?
The canonical SMILES for 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+)) is Cc1cc(-c2cc(F)ccn2)[n-]n1.Cc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Cc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Cc1cnc(-c2cc(C)n[n-]2)cn1.Cc1cnc(-c2cc(C)n[n-]2)cn1.Cc1n[n-]c(-c2cnccn2)c1C.Cc1n[n-]c(-c2cnccn2)n1.Cc1n[n-]c(-c2cnccn2)n1.Fc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.Fc1ccnc(-c2cc(C(F)(F)F)n[n-]2)c1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+))?
The InChIKey is APQFVUUKAJLOQX-UHFFFAOYSA-N. The full InChI is InChI=1S/2C10H7F3N3.2C9H4F4N3.C9H7FN3.3C9H9N4.2C7H6N5.5Pt/c2*1-6-2-3-14-7(4-6)8-5-9(16-15-8)10(11,12)13;2*10-5-1-2-14-6(3-5)7-4-8(16-15-7)9(11,12)13;1-6-4-9(13-12-6)8-5-7(10)2-3-11-8;2*1-6-3-8(13-12-6)9-5-10-7(2)4-11-9;1-6-7(2)12-13-9(6)8-5-10-3-4-11-8;2*1-5-10-7(12-11-5)6-4-8-2-3-9-6;;;;;/h2*2-5H,1H3;2*1-4H;2-5H,1H3;3*3-5H,1-2H3;2*2-4H,1H3;;;;;/q10*-1;5*+2.
What are the key properties of 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+))?
2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+)) has a molecular weight of 2904.13 g/mol, XLogP of 14.65, 10 rotatable bonds, 0 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4,5-dimethylpyrazol-2-id-3-yl)pyrazine;4-fluoro-2-(5-methylpyrazol-2-id-3-yl)pyridine;bis(4-fluoro-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);bis(2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyrazine);bis(2-methyl-5-(5-methylpyrazol-2-id-3-yl)pyrazine);bis(4-methyl-2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine);pentakis(platinum(2+)) is sourced from PubChem (CID 157190481), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).